A comparison of cryopreservation methods: Slow-cooling vs. rapid-cooling based on cell viability, oxidative stress, apoptosis, and CD34+ enumeration of human umbilical cord blood mononucleated cells

BMC Research Notes

Ahmad Faried¹  Danny Halim³  Ferry Sandra¹  Tri H Achmad³  Firman F Wirakusumah²  Tono Djuwantono³ 

[1] Stem Cell and Cancer Institute, Jakarta, Indonesia;Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran-Dr. Hasan Sadikin General Hospital, Bandung, Indonesia;Stem Cell Working Group, Faculty of Medicine, Universitas Padjadjaran-Dr. Hasan Sadikin General Hospital, Bandung, Indonesia

关键词: CD34⁺;    apoptosis;    malondialdehyde;    cell viability;    rapid-cooling;    slow-cooling;    cryopreservation;    hematopoietic stem cell;    Human umbilical cord blood;   

Others  :  1167149
DOI  :  10.1186/1756-0500-4-371

 received in 2011-08-14, accepted in 2011-09-26,  发布年份 2011

【 摘 要 】

Background

The finding of human umbilical cord blood as one of the most likely sources of hematopoietic stem cells offers a less invasive alternative for the need of hematopoietic stem cell transplantation. Due to the once-in-a-life time chance of collecting it, an optimum cryopreservation method that can preserve the life and function of the cells contained is critically needed.

Methods

Until now, slow-cooling has been the routine method of cryopreservation; however, rapid-cooling offers a simple, efficient, and harmless method for preserving the life and function of the desired cells. Therefore, this study was conducted to compare the effectiveness of slow- and rapid-cooling to preserve umbilical cord blood of mononucleated cells suspected of containing hematopoietic stem cells. The parameters used in this study were differences in cell viability, malondialdehyde content, and apoptosis level. The identification of hematopoietic stem cells themselves was carried out by enumerating CD34⁺ in a flow cytometer.

Results

Our results showed that mononucleated cell viability after rapid-cooling (91.9%) was significantly higher than that after slow-cooling (75.5%), with a p value = 0.003. Interestingly, the malondialdehyde level in the mononucleated cell population after rapid-cooling (56.45 μM) was also significantly higher than that after slow-cooling (33.25 μM), with a p value < 0.001. The apoptosis level in rapid-cooling population (5.18%) was not significantly different from that of the mononucleated cell population that underwent slow-cooling (3.81%), with a p value = 0.138. However, CD34⁺ enumeration was much higher in the population that underwent slow-cooling (23.32 cell/μl) than in the one that underwent rapid-cooling (2.47 cell/μl), with a p value = 0.001.

Conclusions

Rapid-cooling is a potential cryopreservation method to be used to preserve the umbilical cord blood of mononucleated cells, although further optimization of the number of CD34⁺ cells after rapid-cooling is critically needed.

【 授权许可】

   
2011 Djuwantono et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D: Human umbilical cord blood as a potential source of transplantation hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989, 86:3828-3832.
• [2]Agarwal MB: Umbilical cord blood transplantation: newer trends. JAPI 2006, 54:143-147.
• [3]Ballen KK, Barker JN, Stewart SK, Greene MF, Lane TA: Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant 2008, 14:356-363.
• [4]Armson BA, Maternal/Fetal Medicine Committee, Society of Obstetricians and Gynaecologists of Canada: Umbilical cord blood banking: implications for perinatal care providers. J Obstet Gynaecol Can 2005, 27:263-290.
• [5]Rocha V, Cornish J, Sievers EL: Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001, 97:2962-2971.
• [6]Karlsson JO, Toner M: Long-term storage of tissues by cryopreservation: critical issues. Biomaterials 1996, 17:243-256.
• [7]Özkavukcu S, Erdemli E: Cryopreservation: basic knowledge and biophysical effects. J Ankara Medical School 2002, 24:187-196.
• [8]Fahy GM: Vitrification. In Low Temperature Biotechnology: Emerging Applications and Engineering Contributions. Edited by McGrath JJ, Diller KR. New York; 1988:113.
• [9]Liebermann J, Nawroth F, Isachenko V, Isachenko E, Rahimi G, Tucker MJ: Potential importance of vitrification in reproductive medicine. Biol Reprod 2002, 67:1671-1680.
• [10]Orief Y, Schultze-Mosgau A, Dafopoulos K, Al-Hasani S: Vitrification: will it replace the conventional gamete cryopreservation techniques? Middle East Fert Soc J 2005, 10:171-183.
• [11]Isachenko E, Isachenko V, Katkov I, Dessole S, Nawroth F: Vitrification of mammalian spermatozoa in the absence of cryoprotectants: from past practical difficulties to present success. Reprod Biomed Online 2003, 6:191-200.
• [12]Isachenko E, Isachenko V, Katkov II, Rahimi G, Schöndorf T, Mallmann P, Dessole S, Nawroth F: DNA integrity and motility of human spermatozoa after standard slow freezing versus cryoprotectant-free vitrification. Hum Reprod 2004, 19:932-939.
• [13]Chen SU, Lien YR, Chao KH, Lu HF, Ho HN, Yang YS: Cryopreservation of mature human oocytes by rapid-cooling with ethylene glycol in straws. Fertil Steril 2000, 74:804-808.
• [14]Liebermann J, Tucker MJ, Graham JR, Han T, Davis A, Mathiopoulou H, Stillman RJ, Levy MJ: The importance of cooling rate for successful rapid-cooling of human oocytes: comparison of the cryoloop with the flexipet. Biol Reprod 2002, 66(suppl 1):195. (abstract 240)
• [15]Luster SM: Cryopreservation of bovine and caprine oocytes by vitrification. Louisiana: Louisiana State University; 2004.
• [16]Shaw JM, Oranratnachai A, Trounson AO: Cryopreservation of oocytes and embryos. In Handbook of IVF. 2nd edition. Edited by Trounson AO, Gardner D. Boca Raton, Florida:CRC Press; 1999.
• [17]Moore K, Bonilla AQ: Cryopreservation of mammalian embryos: the state of the art. Ann Rev Biomed Sci 2006, 8:19-32.
• [18]Kim HJ, Lee SR, Yoon HJ, Yoon SH, Ko Y, Lim JH: The effect of vitrification on the physiological characteristics of human embryos. In Annual Meeting of the ESHRE 2006. Prague, Czech Republic; 2006:p387.
• [19]Choi DH, Chung HM, Lim JM, Ko JJ, Yoon TK, Cha KY: Pregnancy and delivery of healthy infants developed from vitrified blastocyst in an IVF-ET program. Fertil Steril 2000, 74:838-839.
• [20]Reubinoff BE, Pera MF, Vajta G, Trounson AO: Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod 2001, 16:2187-2194.
• [21]Zhou CQ: Cryopreservation of human embryonic stem cells by vitrification. Chin Med J (Engl) 2004, 117:1050-1055.
• [22]Diaz-Rossello JL: Cord clamping for stem cell donation: medical facts and ethics. NeoReviews 2006, 7:e557-e563.
• [23]Institute NHLB: The Cord Blood Transplantation Study (COBLT), Laboratory Procedures. National Heart Lung and Blood Institute 2003.
• [24]Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I: The ISHAGE guidelines for CD34+ determination by flow cytometry. J Hematother 1996, 5:213-226.
• [25]Rode HJ, Eisel D, Frost I: Apoptosis, cell death, and cell proliferation. [http://www.roche-applied-science.com] webciteRoche Appl Sci 2004.
• [26]Boyse EA, Broxmeyer HE, Douglas GW, inventors; PharmaStem Therapeutics, Inc., assignee: Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood. United States of America patent US Patent 2003, 6569427.
• [27]Bayer ZLA, Hoffman DE, Adams LA, Wilder PT, Reece MT: The effect of processing and cryopreservation on nucleated umbilical cord blood cells. J Perinat Med 2004, 32:430-433.
• [28]Schuffner A, Morshedi M, Oehninger S: Cryopreservation of fractioned, highly motile human spermatozoa: effect on membrane phosphatidylserine externalization and lipid peroxidation. Human Reproduction 2001, 16:2148-2153.
• [29]Paasch U, Sharma RK, Gupta AK, Grunewald S, Mascha EJ, Thomas AJ, Glander H-J, Agarwal A: Cryopreservation and thawing is associated with varying extent of activation of apoptotic machinery in subsets of ejaculated human spermatozoa. Biol Reprod 2004, 71:1828-1837.
• [30]Baumber J, Ball BA, Linfor JJ, Meyers SA: Reactive oxygen species and cryopreservation promote DNA fragmentation in equine spermatozoa. Journal of Andrology 2003, 24:621-628.
• [31]Krause DS, Fackler MJ, Civin CI, May WS: CD34: Structure, biology and clinical utility. Blood 1996, 87:1-13.
• [32]Huss R: Isolation of primary and immortalized CD34- hematopoietic and mesenchymal stem cells from various sources. Stem Cells 2000, 18:1-9.